Durvalumab vs Lovastatin

Durvalumab vs Lovastatin: Overview

This comparison examines the pharmacological differences between Durvalumab and Lovastatin.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Lovastatin: First naturally derived statin; prodrug hydrolyzed to active beta-hydroxy acid inhibiting HMG-CoA reductase.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Lovastatin — 2-3 hours.

Chemical Properties

Molecular Formula: Lovastatin — C24H36O5.

Molecular Weight: Lovastatin — 404.5390 g/mol.

Type: Durvalumab — Antibody; Lovastatin — Small molecule.